p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin
| dc.contributor.author | Xiao, Q.X. | |
| dc.contributor.author | Xue, L.L. | |
| dc.contributor.author | Tan, Y.X. | |
| dc.contributor.author | Huangfu, L.R. | |
| dc.contributor.author | Chen, L. | |
| dc.contributor.author | Zhai, C.Y. | |
| dc.contributor.author | Ma, R.F. | |
| dc.contributor.author | Al Hawwas, M. | |
| dc.contributor.author | Zhou, H.S. | |
| dc.contributor.author | Wang, T.H. | |
| dc.contributor.author | Zhou, X.F. | |
| dc.contributor.author | Xiong, L.L. | |
| dc.date.issued | 2024 | |
| dc.description | Data source: Supplementary material, https://doi.org/10.1016/j.biopha.2024.117338 | |
| dc.description.abstract | A recent study has introduced a recombinant fusion protein, consisting of the extracellular domain (ECD) of p75 and the Fc fragment of human immunoglobulin IgG1 (p75ECD-Fc), as a multifaceted agent within the nervous system. This research aimed to assess the effects of p75ECD-Fc on neuronal growth and the restoration of neurological functions in rats afflicted with neonatal hypoxic-ischemic encephalopathy (NHIE). In vitro analyses revealed that 1 μM p75ECD-Fc treatment markedly increased cell viability and facilitated neurite outgrowth in neurons exposed to oxygen-glucose deprivation (OGD). Subsequent in vivo studies determined that a dose of 78.6 μg/3 μl of p75ECD-Fc significantly mitigated brain damage and both acute and long-term neurological impairments, outperforming the therapeutic efficacy of hypothermia, as evidenced through behavioral assessments. Additionally, in vivo immunostaining showed that p75ECD-Fc administration enhanced neuronal survival and regeneration, and reduced astrocytosis and microglia activation in the cortex and hippocampus of NHIE rats. A noteworthy shift from A1 to A2 astrocyte phenotypes and from M1 to M2 microglia phenotypes was observed after p75ECD-Fc treatment. Furthermore, a co-expression of the p75 neurotrophin receptor (p75NTR) and Nestin was identified, with an overexpression of Nestin alleviating the neurological dysfunction induced by NHIE. Mechanistically, the neuroprotective effects of p75ECD-Fc, particularly its inhibition of neuronal apoptosis post-OGD, may be attributed to Nestin. Taken together, these results highlight the neuroprotective and anti-inflammatory effects of p75ECD-Fc treatment through the modulation of glial cell phenotypes and the Nestin-mediated inhibition of neuronal apoptosis, positioning it as a viable therapeutic approach for NHIE. | |
| dc.identifier.citation | Biomedicine & Pharmacotherapy, 2024; 179(117338):1-17 | |
| dc.identifier.doi | 10.1016/j.biopha.2024.117338 | |
| dc.identifier.issn | 0753-3322 | |
| dc.identifier.issn | 1950-6007 | |
| dc.identifier.orcid | Zhou, X.F. [0000-0002-8687-0175] | |
| dc.identifier.uri | https://hdl.handle.net/11541.2/40217 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Masson | |
| dc.relation.funding | Zunyi Medical University 12345 Future Talent Training Program-Technology Elite ZYSE-2021–03 | |
| dc.relation.funding | Guizhou Provincial Higher Education Science and Technological Innovation Team [2023]072 | |
| dc.relation.funding | Guizhou Province Distinguished Young Scientific and Technological Talent Program YQK[2023]040 | |
| dc.relation.funding | National Natural Science Foundation of China 82001604 | |
| dc.relation.funding | National Natural Science Foundation of China 82060243 | |
| dc.relation.funding | Zunyi Science and Technology Bureau [2021] 39 | |
| dc.rights | Copyright 2024 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/) | |
| dc.source.uri | https://doi.org/10.1016/j.biopha.2024.117338 | |
| dc.subject | glial polarization | |
| dc.subject | neonatal hypoxic-ischemic encephalopathy | |
| dc.subject | Nestin | |
| dc.subject | neuronal survival and regeneration | |
| dc.subject | p75ECD-Fc | |
| dc.subject | Microglia | |
| dc.subject | Neurons | |
| dc.subject | Animals | |
| dc.subject | Animals, Newborn | |
| dc.subject | Humans | |
| dc.subject | Rats | |
| dc.subject | Rats, Sprague-Dawley | |
| dc.subject | Hypoxia-Ischemia, Brain | |
| dc.subject | Disease Models, Animal | |
| dc.subject | Receptors, Nerve Growth Factor | |
| dc.subject | Recombinant Fusion Proteins | |
| dc.subject | Neuroprotective Agents | |
| dc.subject | Apoptosis | |
| dc.subject | Cell Survival | |
| dc.subject | Immunoglobulin Fc Fragments | |
| dc.subject | Male | |
| dc.title | p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin | |
| dc.type | Journal article | |
| pubs.publication-status | Published | |
| ror.fileinfo | 12292217390001831 13292217380001831 p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin | |
| ror.mmsid | 9916905329301831 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin.pdf
- Size:
- 21.36 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version